Cover Image

Non-alcoholic fatty liver disease: from understanding risk factors to finding optimal treatment regimens: A review

Non-alcoholic fatty liver disease (NAFLD) is now a major risk factor for death among patients with liver disease. Currently, drugs that primarily affect surrogate markers of NAFLD are available. However, none of these drugs showed a significant effect on the course of steatohepatitis and fibrogenesi...

Full description

Saved in:
Bibliographic Details
Main Authors: Daria A. Teplyuk (Author), Aliya A. Kaisina (Author), Shabnam I. Ibragimova (Author), Afina A. Bestavashvili (Author), Irina O. Tinkova (Author), Evgeniia Iu. Pashkova (Author), Jamilya A. Kaibullayeva (Author), Alexander V. Nersesov (Author), Chavdar S. Pavlov (Author)
Format: Book
Published: ZAO "Consilium Medicum", 2023-08-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Non-alcoholic fatty liver disease (NAFLD) is now a major risk factor for death among patients with liver disease. Currently, drugs that primarily affect surrogate markers of NAFLD are available. However, none of these drugs showed a significant effect on the course of steatohepatitis and fibrogenesis. The search for the most relevant lifestyle modification programs is still a priority in comprehensive treatment. A clinical case of follow-up of a comorbid patient is presented. Despite comprehensive treatment, disease regression was not achieved. NAFLD therapy remains a relevant issue. Finding new ways to affect the NAFLD course and individualize treatment approaches is necessary.
Item Description:2075-1753
2542-2170
10.26442/20751753.2023.5.202272

Similar Items